Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Thoracic Cancer|December 20, 2021
Development and validation of a prediction model using molecular marker for long-term survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapyYufan Yang, Tao Zhang, Zongmei Zhou, et al.
Clinical Medicine Insights. Oncology|March 7, 2022
Local Therapy Combined With First-Line EGFR Tyrosine Kinase Inhibitor Achieves Favorable Survival in Patients With EGFR-Mutant Metastatic Non-Small Cell Lung CancerXiaotong Lu, Jingbo Wang, Chunyu Wang, et al.
Cancers|October 14, 2022
A Single Center Analysis of Thymic Neuroendocrine TumorsYirui Zhai, Qiang Zeng, Nan Bi, et al.
Radiation Oncology (London, England)|March 29, 2022
Chemoradiotherapy is an alternative choice for patients with primary mediastinal seminomaYirui Zhai, Bo Chen, Xiaoli Feng, et al.
Clinical and Translational Radiation Oncology|March 1, 2024
Nodal recurrence mapping and clinical target volumes after resection of intrahepatic cholangiocarcinoma or combined hepatocellular-cholangiocarcinomaZhuanbo Yang, Liming Wang, Yirui Zhai, et al.
Liver Cancer|June 23, 2025
Chinese Expert Consensus on the Combination of Targeted Therapy and Immunotherapy with Locoregional Therapy for Intermediate/Advanced Hepatocellular CarcinomaXinyu Bi, Yinying Lu, Bo Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 8, 2021
A validation study on the lung immune prognostic index for prognostic value in patients with locally advanced non-small cell lung cancerTao Zhang, Wenji Xue, Daquan Wang, et al.
Oncotargets and Therapy|November 16, 2013
Nimotuzumab combined with radiotherapy for esophageal cancer: preliminary study of a Phase II clinical trialJun Liang, Mingyan E, Gang Wu, et al.
BMC Cancer|September 23, 2020
A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocolLin-Rui Gao, Xin Wang, Weiming Han, et al.
JHEP Reports : Innovation in Hepatology|February 21, 2025
Phase II study with sorafenib plus radiotherapy for advanced HCC with portal and/or hepatic vein tumor thrombosisYirui Zhai, Liming Wang, Hong Zhao, et al.
Pageof 7